{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:52:06Z","timestamp":1760147526029,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kaohsiung Medical University Hospital","award":["KMUH108-8R17","KMUH109-9R13"],"award-info":[{"award-number":["KMUH108-8R17","KMUH109-9R13"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Interstitial pneumonia with autoimmune features (IPAF) is a new disease entity proposed in 2015. Numerous questions regarding IPAF require clarification, including diagnostic criteria, standard managements for stable disease and exacerbation, and prognosis. We report a case of a 67-year-old Asian woman who presented with progressive dyspnea. Chest computed tomography (CT) scans revealed nonspecific interstitial pneumonia. Serologic testing indicated positive anti-Jo-1 without presence of extrathoracic manifestations. An IPAF diagnosis was made after a multidisciplinary discussion. The patient experienced a severe exacerbation requiring mechanical ventilation, and she was successfully salvaged with methylprednisolone pulse therapy and single-dose cyclophosphamide. During the one-year follow-up, she reported bilateral leg muscle weakness with noticeably elevated serum creatine kinase, suggesting polymyositis. The development of malignancy was also noted 15 months after the initial presentation, and the patient eventually died. This report demonstrated successful salvage treatment with glucocorticoid pulse therapy for IPAF with acute exacerbation. However, the maintenance therapy failed to control disease progression. The treatment strategies for exacerbation and stable disease in IPAF remain unknown and need further studies. Given the high risk of evolution into a defined connective tissue disease (CTD), regular evaluation of the clinical features and biomarkers of CTDs is essential for patients with IPAF.<\/jats:p>","DOI":"10.3390\/medicina59020330","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T04:48:03Z","timestamp":1676004483000},"page":"330","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent Exacerbations and Evolution into Polymyositis in a Patient with Interstitial Pneumonia with Autoimmune Features: A Case Report and Literature Review"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7337-384X","authenticated-orcid":false,"given":"Chien-Tzu","family":"Huang","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsan-Teng","family":"Ou","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui-Sheng","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan"},{"name":"Department of Radiology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hung","family":"Cheng","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-3749","authenticated-orcid":false,"given":"Chau-Chyun","family":"Sheu","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan"},{"name":"Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: Interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fmed.2019.00209","article-title":"Interstitial Pneumonia With Autoimmune Features (IPAF)","volume":"6","author":"Fernandes","year":"2019","journal-title":"Front. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1513\/AnnalsATS.201808-565CME","article-title":"Interstitial Pneumonia with Autoimmune Features","volume":"16","author":"Graney","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon","year":"2011","journal-title":"J. Bras. Pneumol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rmed.2016.10.017","article-title":"Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients","volume":"123","author":"Ahmad","year":"2017","journal-title":"Respir. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rmed.2016.09.002","article-title":"Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience","volume":"119","author":"Chartrand","year":"2016","journal-title":"Respir. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s10067-018-4111-5","article-title":"Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: A population-based study","volume":"37","author":"Dai","year":"2018","journal-title":"Clin. Rheumatol."},{"doi-asserted-by":"crossref","unstructured":"Ito, Y., Arita, M., Kumagai, S., Takei, R., Noyama, M., Tokioka, F., Nishimura, K., Koyama, T., Notohara, K., and Ishida, T. (2017). Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features. BMC Pulm. Med., 17.","key":"ref_8","DOI":"10.1186\/s12890-017-0453-z"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/resp.13665","article-title":"Long-term clinical course and outcome of interstitial pneumonia with autoimmune features","volume":"25","author":"Kim","year":"2020","journal-title":"Respirology"},{"doi-asserted-by":"crossref","unstructured":"Lim, J.U., Gil, B.M., Kang, H.S., Oh, J., Kim, Y.H., and Kwon, S.S. (2019). Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis. BMC Pulm. Med., 19.","key":"ref_10","DOI":"10.1186\/s12890-019-0868-9"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1183\/13993003.01565-2015","article-title":"Characterisation of patients with interstitial pneumonia with autoimmune features","volume":"47","author":"Oldham","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.rmed.2018.02.024","article-title":"Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia","volume":"137","author":"Yoshimura","year":"2018","journal-title":"Respir. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"210177","DOI":"10.1183\/16000617.0177-2021","article-title":"Interstitial pneumonia with autoimmune features: Challenges and controversies","volume":"30","author":"Mackintosh","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: What progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1136\/annrheumdis-2019-215484","article-title":"Comment on: \u2018Idiopathic inflammatory myopathies and antisynthetase syndrome: Contribution of antisynthetase antibodies to improve current classification criteria\u2019 by Greco et al","volume":"79","author":"Knitza","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.chest.2019.08.2175","article-title":"The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features","volume":"157","author":"Sambataro","year":"2020","journal-title":"Chest"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/rheumatology\/kez404","article-title":"Risk of progression of interstitial pneumonia with autoimmune features to a systemic autoimmune rheumatic disease","volume":"59","author":"Alevizos","year":"2020","journal-title":"Rheumatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"102451","DOI":"10.1016\/j.autrev.2019.102451","article-title":"Interstitial pneumonia with autoimmune features: A single center prospective follow-up study","volume":"19","author":"Sebastiani","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2021.12.021","article-title":"Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-up","volume":"97","author":"Decker","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/RHU.0000000000001847","article-title":"Identification and Prognosis of Patients With Interstitial Pneumonia With Autoimmune Features","volume":"28","author":"Jiwrajka","year":"2022","journal-title":"J. Clin. Rheumatol."},{"doi-asserted-by":"crossref","unstructured":"De Lorenzis, E., Bosello, S.L., Varone, F., Sgalla, G., Calandriello, L., Natalello, G., Iovene, B., Cicchetti, G., Gigante, L., and Verardi, L. (2020). Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement. Diagnostics, 10.","key":"ref_21","DOI":"10.3390\/diagnostics10090664"},{"doi-asserted-by":"crossref","unstructured":"Sebastiani, M., Faverio, P., Manfredi, A., Cassone, G., Vacchi, C., Stainer, A., Pozzi, M.R., Salvarani, C., Pesci, A., and Luppi, F. (2020). Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential. Biomedicines, 9.","key":"ref_22","DOI":"10.3390\/biomedicines9010017"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"h6819","DOI":"10.1136\/bmj.h6819","article-title":"Management of interstitial lung disease associated with connective tissue disease","volume":"352","author":"Mathai","year":"2016","journal-title":"Bmj"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/art.40679","article-title":"Interstitial Pneumonia With Autoimmune Features: An Emerging Challenge at the Intersection of Rheumatology and Pulmonology","volume":"70","author":"Wilfong","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J. Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/resp.12214","article-title":"Rituximab in severe, treatment-refractory interstitial lung disease","volume":"19","author":"Keir","year":"2014","journal-title":"Respirology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1702519","DOI":"10.1183\/13993003.02519-2017","article-title":"Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF)","volume":"51","author":"Wiertz","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: A double-blind, randomised, placebo-controlled, phase 2 trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.55563\/clinexprheumatol\/off5n7","article-title":"The role of pirfenidone in the treatment of interstitial pneumonia with autoimmune features","volume":"40","author":"Chen","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e031444","DOI":"10.1136\/bmjopen-2019-031444","article-title":"Systematic review and meta-analysis of the prognosis and prognostic factors of interstitial pneumonia with autoimmune features","volume":"9","author":"Kamiya","year":"2019","journal-title":"BMJ Open"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3899\/jrheum.161480","article-title":"Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies","volume":"44","author":"Shi","year":"2017","journal-title":"J. Rheumatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2001205","DOI":"10.1183\/13993003.01205-2020","article-title":"Myositis-specific Antibodies Identify A Distinct Interstitial Pneumonia with Autoimmune Features Phenotype","volume":"56","author":"Graham","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0190-9622(82)70018-0","article-title":"The value of malignancy evaluation in patients with dermatomyositis","volume":"6","author":"Callen","year":"1982","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/2\/330\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:30:00Z","timestamp":1760121000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/2\/330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["medicina59020330"],"URL":"https:\/\/doi.org\/10.3390\/medicina59020330","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2023,2,10]]}}}